Drug metabolism in dog liver slices assessed as (2R,2'R)-2,2'-(diimidazo[4,5-b:4',5'-e]pyridine-1,7-diyl)bis(2-(4-fluorophenyl)-1-(pyrrolidin-1-yl)pro...

Basic Information

ID: ALA3530044

Type: ADME

Description: Drug metabolism in dog liver slices assessed as (2R,2'R)-2,2'-(diimidazo[4,5-b:4',5'-e]pyridine-1,7-diyl)bis(2-(4-fluorophenyl)-1-(pyrrolidin-1-yl)propan-1-one) formation at 50 uM after 24 hrs

Format: BAO_0000221

Organism: Canis lupus familiaris

Tissue: Liver

Target: Liver(ALA613430)

Document: ALA3525909

Drug metabolism in dog liver slices assessed as (2R,2'R)-2,2'-(diimidazo[4,5-b:4',5'-e]pyridine-1,7-diyl)bis(2-(4-fluorophenyl)-1-(pyrrolidin-1-yl)propan-1-one) formation at 50 uM after 24 hrs: 1

Associated Items: Associated Bioactivities Associated Compounds

Activity Charts

Bioactivity

Activity Types for Assay ALA3530044

Drug metabolism

Total(1)

Parent Molecular Weight	ALogP	Polar Surface Area
562.69	3.59	3.59

Parent Molecular Weight

ALogP

Polar Surface Area

562.69

3.59

Drug metabolism in dog liver slices assessed as (2R,2'R)-2,2'-(diimidazo[4,5-b:4',5'-e]pyridine-1,7-diyl)bis(2-(4-fluorophenyl)-1-(pyrrolidin-1-yl)pro...

Basic Information

Activity Charts

Compound Summary